References
- American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2014;37:S81–90
- American Diabetes Association. Standards of medical care in diabetes–2011. Diabetes Care 2011;34:S11–61
- Ben-Haroush A, Yogev Y and Hod M. Epidemiology of gestational diabetes mellitus and its association with Type 2 diabetes. Diabet Med 2004;21:103–13
- Pettitt DJ, Bennett PH and Saad MFet al. Abnormal glucose tolerance during pregnancy in Pima Indian women. Long-term effects on offspring. Diabetes 1991;40:126–130
- Fu G, Brkic J, Hayder H and Peng C. MicroRNAs in human placental development and pregnancy complications. Int J Mol Sci 2013;14:5519–44
- Guay C and Regazzi R. Circulating microRNAs as novel biomarkers for diabetes mellitus. Nat Rev Endocrinol 2013;9:513–21
- Zeng Y and Cullen BR. Recognition and cleavage of primary microRNA transcripts. Methods Mol Biol 2006;342:49–56
- He L and Hannon GJ. MicroRNAs: small RNAs with a big role in gene regulation. Nat Rev Genet 2004;5:522–31
- Collares CV, Evangelista AF and Xavier DJet al. Identifying common and specific microRNAs expressed in peripheral blood mononuclear cell of type 1, type 2, and gestational diabetes mellitus patients. BMC Res Notes 2013;6:491
- Zhao C, Dong J and Jiang Tet al. Early second-trimester serum miRNA profiling predicts gestational diabetes mellitus. PLoS One 2011;6:e23925
- Sand M, Gambichler T and Skrygan Met al. Expression levels of the microRNA processing enzymes Drosha and dicer in epithelial skin cancer. Cancer Invest 2010;28:649–53
- Sand M, Skrygan M and Georgas Det al. Expression levels of the microRNA maturing microprocessor complex component DGCR8 and the RNA-induced silencing complex (RISC) components argonaute-1, argonaute-2, PACT, TARBP1, and TARBP2 in epithelial skin cancer. Mol Carcinog 2012;51:916–22
- Livak KJ and Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001;25:402–8
- Yan J and Yang H. Gestational diabetes mellitus, programing and epigenetics. J Matern Fetal Neonatal Med 2014;27:1266–9
- Fernandez-Morera JL, Rodriguez-Rodero S, Menendez-Torre E and Fraga MF. The possible role of epigenetics in gestational diabetes: cause, consequence, or both. Obstet Gynecol Int 2010;2010:605163
- Peschansky VJ and Wahlestedt C. Non-coding RNAs as direct and indirect modulators of epigenetic regulation. Epigenetics 2014;9:3–12
- Jafari N, Dogaheh HP and Bohlooli Set al. Expression levels of microRNA machinery components Drosha, Dicer and DGCR8 in human (AGS, HepG2, and KEYSE-30) cancer cell lines. Int J Clin Exp Med 2013;6:269–74
- Zhao Z, Moley KH and Gronowski AM. Diagnostic potential for miRNAs as biomarkers for pregnancy-specific diseases. Clin Biochem 2013;46:953–60
- Chim SS, Shing TK and Hung ECet al. Detection and characterization of placental microRNAs in maternal plasma. Clin Chem 2008;54:482–90